D-0394-2025 Class II Ongoing
FDA drug recall D-0394-2025 was initiated by ACCORD HEALTHCARE, INC. on Apr 10, 2025 and is designated Class II. Reason for recall: Subpotent The recall status is ongoing. Affected quantity: 4,888 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 7, 2025
- Initiation Date
- Apr 10, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,888 Bottles
Product description
Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-447-17
Reason for recall
Subpotent
Distribution pattern
Nationwide US.
Code information
Lot # D2300323, Exp Date: 01/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0394-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026